orotic acid has been researched along with Carcinoma, Anaplastic in 6 studies
Orotic Acid: An intermediate product in PYRIMIDINE synthesis which plays a role in chemical conversions between DIHYDROFOLATE and TETRAHYDROFOLATE.
orotic acid : A pyrimidinemonocarboxylic acid that is uracil bearing a carboxy substituent at position C-6.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Variants of the Lewis lung carcinoma were selected for resistance to N-(phosphonacetyl)-L-aspartic acid (PALA) by treatment of tumor-bearing mice with repetitive subcurative doses of PALA." | 7.66 | Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. ( Ardalan, B; Cooney, DA; Cysyk, RL; Han, N; Hankerson, JG; Harley, C; Jayaram, HN; Johnson, RK; Kensler, TW; Mutter, G; Reck, LJ, 1981) |
| "Variants of the Lewis lung carcinoma were selected for resistance to N-(phosphonacetyl)-L-aspartic acid (PALA) by treatment of tumor-bearing mice with repetitive subcurative doses of PALA." | 3.66 | Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid. ( Ardalan, B; Cooney, DA; Cysyk, RL; Han, N; Hankerson, JG; Harley, C; Jayaram, HN; Johnson, RK; Kensler, TW; Mutter, G; Reck, LJ, 1981) |
| "5-Fluorouracil (FUra) is a clinically useful antineoplastic agent." | 1.27 | Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid. ( Casper, ES; Martin, DS; Vale, K; Williams, LJ; Young, CW, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| WILCZOK, T | 1 |
| HEINRIKSON, RL | 1 |
| GOLDWASSER, E | 1 |
| SCAIFE, JF | 1 |
| POPOVIC, DA | 1 |
| Casper, ES | 1 |
| Vale, K | 1 |
| Williams, LJ | 1 |
| Martin, DS | 1 |
| Young, CW | 1 |
| Kensler, TW | 1 |
| Mutter, G | 1 |
| Hankerson, JG | 1 |
| Reck, LJ | 1 |
| Harley, C | 1 |
| Han, N | 1 |
| Ardalan, B | 1 |
| Cysyk, RL | 1 |
| Johnson, RK | 1 |
| Jayaram, HN | 1 |
| Cooney, DA | 1 |
6 other studies available for orotic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
STUDIES ON THE INCORPORATION OF HETEROLOGOUS RNA INTO NEOPLASTIC CELLS.
Topics: Animals; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Metabolism; Mice; Neoplasms; Orotic A | 1963 |
STUDIES ON THE BIOSYNTHESIS OF 5-RIBOSYLURACIL 5'-MONOPHOSPHATE IN TETRAHYMENA PYRIFORMIS.
Topics: Animals; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Chromatography; Diphosphates; Ligases | 1964 |
THE EFFECT OF X-IRRADIATION ON THE METABOLISM OF RIBONUCLEIC ACID IN THE NUCLEI OF THYMOCYTES AND EHRLICH ASCITES CARCINOMA CELLS.
Topics: Animals; Ascites; Carcinoma; Carcinoma, Ehrlich Tumor; Cell Nucleus; Metabolism; Nucleotides; Orotic | 1965 |
[ANTIBIOTICS AS INHIBITORS OF RNA BIOSYNTHESIS IN NEOPLASTIC TISSUE. INCORPORATION OF 2-C-14 OROTIC ACID INTO THE RNA OF EHRLICH CARCINOMA IN VARIOUS CONCENTRATIONS OF ACTINOMYCIN D].
Topics: Animals; Anti-Bacterial Agents; Carbon Isotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Dactinomycin; | 1964 |
Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Aspartic Acid; Blood Cell Count; Carcinoma; Drug Admin | 1983 |
Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
Topics: Amides; Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Carcinoma; Cell Line; Dose-Response | 1981 |